about
Lung donor selection criteriaAn international comparison of the effect of policy shifts to organ donation following cardiocirculatory death (DCD) on donation rates after brain death (DBD) and transplantation rates.Lung transplantation from donors after circulatory death using portable ex vivo lung perfusionSurvival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure.Intimacy or utility? Organ donation and the choice between palliation and ventilation.Analysis of knowledge of the general population and health professionals on organ donation after cardiac death.Lung Quality and Utilization in Controlled Donation After Circulatory Determination of Death Within the United States.Transplantation of the pancreas.Regional perfusion by extracorporeal membrane oxygenation of abdominal organs from donors after circulatory death: a systematic review.Utilization of organs from donors after circulatory death for vascularized pancreas and islet of Langerhans transplantation: recommendations from an expert group.Recommendations for donation after circulatory death kidney transplantation in Europe.In-hospital logistics: what are the key aspects for succeeding in each of the steps of the process of controlled donation after circulatory death?A Comprehensive Analysis of the Current Status and Unmet Needs in Kidney Transplantation in Southeast Asia.Controlled Donation After Circulatory Determination of Death.What information about donation after circulatory death is available on the Internet for potential donor families?Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic.Successful Transplantation of Lungs From an Uncontrolled Donor After Circulatory Death Preserved In Situ by Alveolar Recruitment Maneuvers and Assessed by Ex Vivo Lung Perfusion.Posttransplant Outcomes of Kidneys Donated After Brain Death Followed by Circulatory Death: A Cohort Study of 128 Chinese Patients.Donor Hemodynamics as a Predictor of Outcomes After Kidney Transplantation From Donors After Cardiac Death.The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma.Liver transplant outcomes using ideal donation after circulatory death livers are superior to using older donation after brain death donor livers.Liver damage during organ donor procurement in donation after circulatory death compared with donation after brain death (Br J Surg 2013; 100: 381-386).Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.Report of the first five DCDD pancreas transplants within the Eurotransplant region; excellent results with prolonged first warm ischemia times.Liver graft preservation using perfluorocarbon improves the outcomes of simulated donation after cardiac death liver transplantation in rats.Preliminary results of transplantation with kidneys donated after cardiac death: a path of hope for organ transplantation in China.Harms of unsuccessful donation after circulatory death: An exploratory study.External validation of prediction models for time to death in potential donors after circulatory death.Kidney transplantation from donors after cardiac death: an initial report of 71 cases from China.Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.Improving the Outcomes of Organs Obtained From Controlled Donation After Circulatory Death Donors Using Abdominal Normothermic Regional Perfusion.Dual temperature multi-organ recovery from a Maastricht category III donor after circulatory death.Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.A 10min "no-touch" time - is it enough in DCD? A DCD animal study.Ethical Issues in the Use of Extracorporeal Membrane Oxygenation in Controlled Donation After Circulatory Determination of Death.Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.Donation after Circulatory Death in Paediatric Liver Transplantation: Current Status and Future Perspectives in the Machine Perfusion Era.Donor risk indices in pancreas allocation in the Eurotransplant region
P2860
Q26999347-F68497C5-1398-4787-B60C-8F2EE1D7F39CQ34716992-78A985FD-3409-4E21-83CB-6EDE578A3E39Q35073139-51332384-40B3-4965-8C49-56099DD32EFDQ35988322-A582ACF0-0EF9-4F1F-BA18-01FD91A391CEQ36998621-038B78EE-70CF-4955-8908-CD4A99A191E7Q37311845-25596BDD-9632-4465-8163-366B05A94F84Q37378473-B6994E94-CF22-44B4-A9DC-415E92E823CBQ38029245-6ADDE9EC-BC8E-4D51-A074-0FDA4B580A12Q38153662-EBD83B3A-AABD-4FEE-B841-7216D9744184Q38580738-947581FF-B25A-4345-AFD2-3C1AA49950D8Q38580760-71090EA1-FE94-49F1-B263-82C2005CC7D3Q38615588-17B32C53-C514-4C38-A00B-19046D730121Q38687177-40D8AF58-39B6-4117-82A5-C91766FE3676Q38746374-75C4D67C-3B85-4397-A8F3-1E04FDAB551AQ38863117-13D4DE6A-304B-4653-808C-21CABE288A27Q40580384-70E32DDC-279C-43C3-B3D2-BF2A19E6F29AQ41077771-6D644923-81A8-4B30-8AA4-4592E620ED7EQ41217239-95E98986-FAD5-4DA4-90E5-BBDE0A57C74FQ41372771-998E3AF6-92E1-4BB1-8BD2-E4965E07F8A2Q41742206-4FB71A76-F6F3-4E0B-8DE4-F1AB463E10FFQ42595101-5BE0032E-A86A-4A9A-AD49-53631220C8C0Q44941221-34B5D391-2322-4B4D-AC28-5E836219B255Q45874551-03CAE9E6-6B72-4736-B022-6A668EBF969FQ46309313-62F608F5-964E-4425-A1F8-6461435323B7Q47336964-90F3F1CE-CDF9-4911-B817-8E4586B857A6Q47570472-C7773A6C-24A9-456E-B5E2-C412116551DAQ47570909-BFED30F6-89B4-4A91-B051-C784529BDBA7Q47860382-D7E586D2-0CA1-4B1D-A936-86224846C458Q48138065-6577BD23-AE7C-4419-B24A-0F802426BEF6Q48271802-92B25D37-3EE3-4C39-90A6-94CE2DE5EDFBQ48292947-581E3FC6-5BDC-4249-99CF-1970A683A78BQ48640676-E1FD0911-4C2B-4756-BA61-0B35C98A9785Q48641827-5A89D346-ADEC-4812-9A33-22FC582C697CQ48652629-47972E05-4CD6-4B5B-9BC4-B761F321CB73Q48821083-2350FD01-07EA-4A2C-B00E-8ACBC7DEEBCFQ52668825-39A6A0FD-CBA6-47FC-8A20-39BE3493E731Q55260952-D24DFF00-E593-4752-8EB9-79A66797891FQ57560939-B617FFAD-C112-4D87-9DCA-819A95AA8E02
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Donation after cardiac death: a 29-year experience.
@ast
Donation after cardiac death: a 29-year experience.
@en
type
label
Donation after cardiac death: a 29-year experience.
@ast
Donation after cardiac death: a 29-year experience.
@en
prefLabel
Donation after cardiac death: a 29-year experience.
@ast
Donation after cardiac death: a 29-year experience.
@en
P2093
P2860
P1433
P1476
Donation after cardiac death: a 29-year experience.
@en
P2093
Anthony M D'Alessandro
Chandrasekar Santhanakrishnan
David P Foley
Glen E Leverson
Hans W Sollinger
Janet M Bellingham
Jon S Odorico
Joshua D Mezrich
Luis A Fernandez
P2860
P304
P356
10.1016/J.SURG.2011.07.057
P407
P577
2011-10-01T00:00:00Z